Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Perinatal brain growth and autistic traits in toddlers.

Translational psychiatry·2025

Same author

Oral Health, Inflammation, and Cardiometabolic Factors in the VA Million Veteran Program.

JDR clinical and translational research·2024

Same author

Pediatric tympanostomy tube assessment via deep learning.

American journal of otolaryngology·2024

Same author

Fluctuation of BCR-ABL1 qPCR<sup>IS</sup> level beyond 0.1%<sup>IS</sup> after stopping tyrosine kinase inhibitor in chronic myeloid leukaemia patients with deep molecular response for at least two years.

The Medical journal of Malaysia·2021

Same author

Reference interval establishment of full blood count extended research parameters in the multi-ethnic population of Malaysia.

The Medical journal of Malaysia·2020

Same author

Selection of reference genes for quantitative studies in acute myeloid leukaemia.

The Malaysian journal of pathology·2020

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

National Cancer Patient Registry--Haematology Malignancy (NCPR-HM).

K M Chang¹, T C Ong

¹Department of Haematology, Ampang Hospital, Kuala Lumpur, Malaysia.

The Medical Journal of Malaysia

|February 21, 2009

Summary

Treatment outcomes for hematological malignancies are improving globally. This study assesses treatment results for these cancers in Malaysia, where such data is currently lacking.

Area of Science:

Hematology
Oncology
Public Health

Background:

Treatment options for hematological malignancies have significantly advanced in the past decade.
Improved treatment modalities suggest enhanced patient outcomes compared to previous eras.
There is a notable absence of comprehensive studies evaluating treatment outcomes for hematological malignancies within Malaysia.

Purpose of the Study:

To quantify and analyze the treatment outcomes for patients diagnosed with hematological malignancies in Malaysia.
To establish a baseline understanding of treatment efficacy and patient response within the Malaysian healthcare context.
To identify potential areas for improvement in the management of blood cancers in Malaysia.

Main Methods:

This study will involve a retrospective analysis of patient data.

Related Experiment Videos

Last Updated: Jun 25, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Data collection will focus on key treatment parameters and patient survival rates.

Statistical methods will be employed to analyze treatment outcomes.

Main Results:

Results are pending further analysis.
The study aims to provide quantitative data on treatment success rates.
Findings will shed light on the effectiveness of current treatment protocols.

Conclusions:

Establishing treatment outcomes is crucial for advancing cancer care in Malaysia.
This research will provide essential data to inform clinical practice and health policy.
The findings are expected to contribute to better patient management and survival rates for hematological malignancies.